Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 979798051000036119 | Naropin (ropivacaine hydrochloride monohydrate 200 mg / 100 mL) injection: solution, 5 x 100 mL bags (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 979798061000036116 | Naropin 0.2% (200 mg/100 mL) injection: solution, 5 x 100 mL bags | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Naropin 0.2% (200 mg/100 mL) injection: solution, 5 x 100 mL bags | Is a | containered trade product pack | false | Inferred relationship | Some | ||
| Naropin 0.2% (200 mg/100 mL) injection: solution, 5 x 100 mL bags | Is a | Naropin 0.2% (200 mg/100 mL) injection: solution, 5 x 100 mL bags | false | Inferred relationship | Some | ||
| Naropin 0.2% (200 mg/100 mL) injection: solution, 5 x 100 mL bags | has container type | bag | false | Inferred relationship | Some | ||
| Naropin 0.2% (200 mg/100 mL) injection: solution, 5 x 100 mL bags | has TPUU | Naropin 0.2% (200 mg/100 mL) injection: solution, 100 mL bag | false | Inferred relationship | Some | ||
| Naropin 0.2% (200 mg/100 mL) injection: solution, 5 x 100 mL bags | has TP | Naropin | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set
FHIR